Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Uriel Bohn‐Sarmiento"'
Autor:
Beatriz León-Salas, Amaia Bilbao-González, Ana María de Pascual y Medina, Magdalena Esteva, Ana Toledo-Chávarri, Claudio Fuentes-Sánchez, Uriel Bohn-Sarmiento, Pilar Padrón-Peña, Sonia González-Sánchez, Rafael Valcárcel-López, María del Mar Trujillo-Martín
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeThe aim of this study was to translate, culturally adapt, and evaluate the psychometric properties of the Spanish Long-Term Quality of Life (LTQL) questionnaire.MethodsThe LTQL was initially translated into Spanish and cross-culturally adapted
Externí odkaz:
https://doaj.org/article/3df7e5f2fae9419996b518a367c9905f
Autor:
Beatriz León‐Salas, Yolanda Álvarez‐Pérez, Vanesa Ramos‐García, Mª. del Mar Trujillo‐Martín, Ana María de Pascual y Medina, Magdalena Esteva, Noé Brito‐García, Nerea González‐Hernández, Uriel Bohn‐Sarmiento, M. Concepción Biurrun‐Martínez, Pedro Serrano‐Aguilar
Publikováno v:
European Journal of Cancer Care. 31
The objective of this work is to identify unmet information needs of long-term-survivors of breast cancer (BC) and future research needs from the perspectives of patients and health care professionals.Two online Delphi surveys were conducted. Partici
Autor:
Marta Mori-De Santiago, María Jesús Blanco-Sánchez, David Aguiar-Bujanda, Salvador Saura-Grau, Jose E. Lorenzo-Barreto, María Hernández-Sosa, Saray Galván-Ruíz, Arancha Dueñas-Comino, Laura Ros-Sanjuan, Uriel Bohn-Sarmiento, Ana M. Vargas-Prado
Publikováno v:
Oncology Research and Treatment. 41:755-761
Background: A high neutrophil to lymphocyte ratio (NLR) has been associated with adverse outcomes in non-small cell lung cancer (NSCLC). However, information on epidermal growth factor receptor (EGFR)-mutant advanced NSCLC is scarce, and most of the
Autor:
Grupo Español de Investigación en Cáncer de Ovario, Y. García, Alfonso Cortés Salgado, Ana Oaknin, Uriel Bohn Sarmiento, M. J. Rubio, Maria Iglesias, Antonio González-Martín, Andrés Redondo, Ana Santaballa, Luis Manso Sánchez, Jose Alejandro Perez-Fidalgo, Elisa Calvo García
Publikováno v:
Journal of Clinical Oncology. 39:5549-5549
5549 Background: The prognosis for patients with platinum-resistant/refractory ovarian cancer (PROC) is poor, and the aim of treatment is focused primarily on symptom control and maintenance of QoL. The objective of this study was to assess the impac
Autor:
Carmen Rosa Hernández-Socorro, Uriel Bohn Sarmiento, Pedro Saavedra, Sergio Ruiz-Santana, José Ramírez Felipe
Publikováno v:
Medicina Clínica. 148:345-350
Resumen Antecedentes y objetivo Se evaluaron los factores de riesgo asociados a supervivencia a largo plazo en pacientes con metastasis hepaticas de carcinoma colorrectal sometidos a tratamientos ablativos. Pacientes y metodos Estudio de cohorte unic
Autor:
Carmen Rosa Hernández-Socorro, José Ramírez Felipe, Uriel Bohn Sarmiento, Sergio Ruiz-Santana, Pedro Saavedra
Publikováno v:
Medicina Clínica (English Edition). 148:345-350
Background and objective The risk factors associated to long-term survival were assessed in patients with liver metastases of colorectal carcinoma undergoing ablative therapies. Patients and methods Single-centre cohort study, retrospectively analyze
Autor:
David Aguiar-Bujanda, María Jesús Blanco-Sánchez, Salvador Saura-Grau, Uriel Bohn-Sarmiento, Saray Galván-Ruíz, María Hernández-Sosa, Samuel Hernández-Sarmiento
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:761-765
Background Late-onset neutropenia (LON) is a known adverse effect to rituximab therapy. Information about its real incidence and clinical implications comes from case reports and few retrospective studies specifically designed to study LON. However,
Autor:
Samuel Hernández-Sarmiento, María Jesús Blanco-Sánchez, Uriel Bohn-Sarmiento, Salvador Saura-Grau, David Aguiar-Bujanda, Saray Galván-Ruíz, María Hernández-Sosa, Pedro Jiménez-Gallego, Marta Mori-De Santiago
Publikováno v:
Future Oncology. 10:1967-1980
ABSTRACT The prognosis of follicular lymphoma (FL) has significantly improved over the last decade, particularly following the introduction of the anti-CD20 monoclonal antibody rituximab, which has challenged the old concept of FL as an incurable dis
Autor:
José C. Rivero-Vera, Miguel Angel Limeres-gonzález, Samuel Hernández-Sarmiento, Marta Mori-De Santiago, María Jesús Blanco-Sánchez, Saray Galván-Ruíz, Ignacio Llorca-Mártinez, Salvador Saura Grau, José C. Cabrera-Marrero, María Hernández-Sosa, Pedro Jiménez-Gallego, Uriel Bohn-Sarmiento, David Aguiar-Bujanda
Publikováno v:
Hematological Oncology. 32:139-144
There is no standard treatment for patients with gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) who are resistant to, or ineligible for, anti-Helicobacter pylori (anti-HP) therapy. In this study, we inv
Autor:
José Aguiar Morales, Salvador Saura Grau, David Aguiar Bujanda, Uriel Bohn Sarmiento, Carlos Rodríguez Franco
Publikováno v:
Clinical and Translational Oncology. 11:604-608
Background The results of CHOP-21 (cyclophosphamide, doxorubicin, vincristine and prednisone given every 21 days) for the treatment of aggressive B-cell lymphoma have recently been improved by the addition of rituximab and by increasing the dose dens